BPS Program Book 2014

Name

Disclosure Entity

Disclosure Type

Presentation Number

Schwarzenberger, Tobias

Nanion Technologies

Employment (full or part-time) in funding company 3702-Pos Employment (full or part-time) in funding company 2377-Pos Employment (full or part-time) in funding company 3070-Pos Employment (full or part-time) in funding company 3070-Pos Employment (full or part-time) in funding company 1033-Pos

Sellers, Scott

Gilead Sciences Schrodinger, Inc. Schrodinger, Inc.

Shelley, Mee Y. Shelley, John C. Shetty, Roshan Shorthouse, David Skinner, Joseph P.

Anasys Instruments Corp.

Lonza Biologics plc

Research funded by industry grant

318-Pos

Abbott

Employment (full or part-time) in funding company 996-Pos Employment (full or part-time) in funding company 90-Plat

Slack, Mark Solaro, Ross J.

Evotec AG

Cytokinetics, Inc.

Non-remunerative positions of influence such as officer, board member, trustee, or public spokesperson in company Stock options or bond holdings in a for-profit corporation or self-directed pension plan

2858-Pos

Song, Yonghong

MyoKardia, Inc.

2842-Pos

Song, Zhen

Gilead Sciences Inc., Foster City, California

Research funded by industry grant

3188-Plat

Song, Yonghong Sran, Arvinder

MyoKardia Inc MyoKardia, Inc.

Employment (full or part-time) in funding company 3692-Pos

Stock options or bond holdings in a for-profit corpo- ration or self-directed pension plan

2842-Pos

Sran, Arvinder S. Steindl, Juergen

MyoKardia Inc

Employment (full or part-time) in funding company 3692-Pos Employment (full or part-time) in funding company 680-Pos Employment (full or part-time) in funding company 680-Pos Employment (full or part-time) in funding company 680-Pos Employment (full or part-time) in funding company 3702-Pos Employment (full or part-time) in funding company 3702-Pos Employment (full or part-time) in funding company 694-Pos Consulting fees or other remuneration from industry 875-Pos Employment (full or part-time) in funding company 3861-Pos Employment (full or part-time) in funding company 3267-Plat Employment (full or part-time) in funding company 3687-Pos Employment (full or part-time) in funding company 996-Pos Employment (full or part-time) in funding company 3702-Pos Employment (full or part-time) in funding company 3097-Pos Employment (full or part-time) in funding company 1330-Pos Employment (full or part-time) in funding company 3292-Pos Employment (full or part-time) in funding company 736-Pos Ownership or Partnership in funding organization 2012-Pos Research funded by industry grant Research funded by industry grant 2684-Pos 2684-Pos Research funded by industry grant 2228-Plat

Nanion Technologies Nanion Technologies Nanion Technologies Nanion Technologies Nanion Technologies Nanion Technologies

Stengel, Timo

Stiehler, Johannes Stiehler, Johannes Stoelzle-Feix, Sonja Stoelzle-Feix, Sonja Stolarska, Magdalena

Corning, Inc. Firmenich Inc. Firmenich Inc.

Stone, Howard

Sun, Bo

Sunesen, Morten Sweitzer, Sharon M.

Sophion Bioscience GlaxoSmithKline Trim-edicine, Inc.

Tan, Tao

Tetin, Sergey Y. Thomas, Ulrich Thouin, Félix Tirunagari, Neeraj

Abbott

Nanion Technologies

Photon Etc.

Gilead Sciences Inc.

Tordo, Paul

Bruker

Tracka, Malgorzata B.

Medimmune Ltd.

Tranter, Pamela Trautman, Jay K. Trick, Jemma L. Uddin, Shahid Ullah, Aman Vaissière, Anaïs

Novartis

Aratome LLC

Oxford Nanopore Technologies

Research funded by industry grant

1067-Pos

Medimmune Ltd.

Employment (full or part-time) in funding company 3292-Pos

NVIDIA

Research funded by industry grant Research funded by industry grant

2179-Plat 2409-Pos

Servier

296

Biophysical Society 58 th Annual Meeting, San Francisco, California